Antidiuretic Drugs Market Research Report- Global Forecast till 2027

Antidiuretic Drugs Market Information: By Type (Vasopressin, Desmopressin, Oxytocin, others), By Indication (Diabetes Insipidus, Hemophilia, Hypertension, others), By End Users (Hospitals, Clinics, Pharmaceutical Companies, others) - Global Forecast till 2027

ID: MRFR/Pharma/2938-HCR | February 2021 | Region: Global | 200 pages

Please note that the assessment period of report has been updated from 2023 to 2027. Cordially fill the sample form for updated data.


Market Synopsis of the Global Antidiuretic drugs Market
Market Scenario
Antidiuretic substance helps to control the fluid balance in the body. Their action is opposite to that of diuretics which disrupt this balance. Major antidiuretic drugs are vasopressin (also known as antidiuretic hormone (ADH)), desmopressin, and oxytocin. In diabetes insipidus, antidiuretic drugs reduce the urine volume. Desmopressin is widely used antidiuretic drug as it is relatively inexpensive and safe having minimum adverse reactions to the body. It is primarily used for treating patients with hemophilia.  


Rising prevalence of diabetes and other chronic disease such as cardiovascular diseases, growing use of antidiuretic drugs for the treatment of hemophilia and huge patient pool with hypertension, drives the growth of antidiuretic drugs markets.
The global antidiuretic drugs market is expected to grow at a CAGR of 9.7% during the forecast period and is estimated to reach USD 180 million by 2023.


FIGURE 1 Global Antidiuretic Drugs Market by region, 2016 (%)
Antidiuretic Drugs Market


Key Players in the Global Antidiuretic drugs Market     
Some of the key players in this market are Par Sterile Products, LLC (U.S.), ADH Health (U.S.), Azevan Pharmaceuticals, Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Otsuka Holdings Co. Ltd (Japan), Taj Pharmaceuticals Limited (India) and ALLERGAN (U.S.).
Segments          
The global antidiuretic drugs market is segmented on the basis of types, which includes vasopressin, desmopressin, oxytocin, and others. Other types of antidiuretic drugs are argipressin, lypressin, ornipressin and terlipressin. On the basis of indication, the market is segmented into diabetes insipidus, hemophilia, hypertension, and others. Diabetes insipidus is further sub-segmented into central diabetes insipidus, nephrogenic diabetes insipidus, dipsogenic diabetes insipidus and gestational diabetes insipidus. Other indications are polyuria, polydipsia and enuresis. On the basis of end users, the market is segmented into hospitals, clinics, pharmaceutical companies, and others.

Research Methodology

Global Antidiuretic Drugs Market
Regional Analysis of the Global Antidiuretic drugs Market  
 
   
The American region accounted for the largest share of the global market due to increasing prevalence of diabetes insipidus, and rising demand for new drugs for the treatment of diabetes insipidus. The rate of diabetes insipidus is much higher in America than the rest of the world. According to the Diabetes Insipidus Organization, in the U.S., 1 in 6,666 American may develop diabetes insipidus. According to International Diabetes Federation, in 2016, it was estimated that 420 million adult population was suffering from diabetes which is increasing at the rate of 8.4% and is expected to reach 625 million by 2040.


 


Europe is the second largest market that holds a noticeable share of the global antidiuretic drugs market. Diabetes insipidus is a common postoperative complication among children who have undergone transsphenoidal craniotomy.


In Asia Pacific, rising awareness about diabetes insipidus, huge geriatric population suffering from diabetes insipidus and increase in the risk of developing diabetes insipidus after surgery is driving the market growth. Furthermore, rising awareness about the use of antidiuretic drugs for the treatment of diabetes insipidus also propels the market growth.
Middle East and Africa show steady growth in the antidiuretic drugs market.
The report on the global antidiuretic drugs market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions
Intended Audience



  • Pharmaceutical companies

  • Medical Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors



Frequently Asked Questions (FAQ) :


Antidiuretic Drugs Market valuation would be USD 180 million by 2023.

The companies are ADH Health (U.S.), Par Sterile Products, LLC (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Azevan Pharmaceuticals, Inc. (U.S.), Taj Pharmaceuticals Limited (India), Otsuka Holdings Co. Ltd (Japan), and ALLERGAN (U.S.).

What are the types included in the Antidiuretic Drugs Market?

The indications discussed are hypertension, hemophilia, diabetes insipidus, and others.

Brief TOC

1 Report Prologue

2 Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3 Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

4 Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porters five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain

5.3 Investment Feasibility Analysis

5.4 Price Factor Analysis

6 Global Antidiuretic drugs Market, by Type

6.1 Introduction

6.2 Vasopressin

6.3 Desmopressin

6.4 Oxytocin

6.5 Others

6.5.1 Terlipressin

6.5.2 Argipressin

6.5.3 Lypressin

6.5.4 Ornipressin

7 Global Antidiuretic drugs Market, by Indication

7.1 Introduction

7.2 Diabetes Insipidus

7.2.1 Central Diabetes Insipidus

7.2.2 Nephrogenic Diabetes Insipidus

7.2.3 Dipsogenic Diabetes Insipidus

7.2.3 Gestational Diabetes Insipidus

7.3 Hemophilia

7.4 Hypertension

7.5 Others

7.5.1 Polyuria

7.5.2 Polydipsia

7.5.3 Enuresis

8 Global Antidiuretic drugs Market, by End User

8.1 Introduction

8.2 Hospitals

8.3 Clinics

8.4 Pharmaceutical Companies

8.5 Others

9 Global Antidiuretic drugs Market by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 Latin America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 UK

9.3.1.4 Italy

9.3.1.5 Spain

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Republic of Korea

9.4.5 Australia

9.4.6 Rest of Asia Pacific

9.5 Middle East & Africa

9.5.1 United Arab Emirates

9.5.2 Saudi Arabia

9.5.3 Oman

9.5.4 Kuwait

9.5.5 Qatar

9.5.6 Rest of Middle East & Africa

10 Company Landscape

10.1 Introduction

10.2 Market share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

11 Company Profiles

11.1 Par Sterile Products, LLC

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials

11.1.4 SWOT Analysis

11.2 Azevan Pharmaceuticals, Inc.

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Teva Pharmaceutical Industries Ltd.

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Taj Pharmaceuticals Limited

11.4.1 Company Overview

11.4.2 Product/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 ALLERGAN

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.6 Otsuka Holdings Co. Ltd

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.7 ADH Health

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financials

11.7.4 Key Developments

11.7.5 SWOT Analysis

12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of Healthcare Industry

13 Appendix